Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 3/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | APEX1 | P27695 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31757149 | 0.98 | THRB (0.42) | THRBTSHRALDH1A1POLBAPEX1 | |
| SCHEMBL13024793 | 0.95 | THRB (0.42) | THRBTSHRALDH1A1POLBAPEX1 | |
| SCHEMBL17603217 | 0.94 | THRB (0.39) | THRBTSHRALDH1A1POLBAPEX1 | |
| SCHEMBL711905 | 0.94 | THRB (0.41) | THRBTSHRALDH1A1POLBAPEX1 | |
| SCHEMBL711199 | 0.94 | THRB (0.41) | THRBTSHRALDH1A1POLBAPEX1 | |
| SCHEMBL712016 | 0.94 | THRB (0.41) | THRBTSHRALDH1A1POLBAPEX1 | |
| SCHEMBL27797693 | 0.92 | THRB (0.40) | THRBTSHRALDH1A1POLBAPEX1 | |
| SCHEMBL27776673 | 0.91 | THRB (0.39) | THRBTSHRALDH1A1POLBAPEX1 | |
| SCHEMBL27776676 | 0.91 | THRB (0.39) | THRBTSHRALDH1A1POLBAPEX1 | |
| SCHEMBL1536985 | 0.90 | THRB (0.46) | THRBTSHRALDH1A1POLBAPEX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 320 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3247328-B1 | METHODS, COMPOSITIONS, AND SYSTEMS FOR DELIVERING THERAPEUTIC AND DIAGNOSTIC AGENTS INTO CELLS | GENEVANT SCIENCES GMBH (CH) | 2026-01-07 | — | — | EP | claimed |
| US-20230038687-A1 | METHODS, COMPOSITIONS, AND SYSTEMS FOR DELIVERING THERAPEUTIC AND DIAGNOSTIC AGENTS INTO CELLS | GENEVANT SCIENCES GMBH (CH) | 2023-02-09 | — | — | US | claimed |
| US-20220031847-A1 | THERAPEUTIC METHODS | GENEVANT SCIENCES GMBH (CH) | 2022-02-03 | — | — | US | claimed |
| EP-3873530-A1 | THERAPEUTIC METHODS | Genevant Sciences GmbH (CH) | 2021-09-08 | — | — | EP | claimed |
| US-20200398289-A1 | ARTICLES FOR MANIPULATING IMPINGING LIQUIDS AND ASSOCIATED METHODS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2020-12-24 | — | — | US | claimed |
| US-20190118232-A1 | ARTICLES FOR MANIPULATING IMPINGING LIQUIDS AND ASSOCIATED METHODS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2019-04-25 | — | — | US | claimed |
| EP-3247328-A1 | METHODS, COMPOSITIONS, AND SYSTEMS FOR DELIVERING THERAPEUTIC AND DIAGNOSTIC AGENTS INTO CELLS | PhaseRx, Inc. (US) | 2017-11-29 | — | — | EP | claimed |
| US-9498934-B2 | Grafted polymer surfaces for dropwise condensation, and associated methods of use and manufacture | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2016-11-22 | — | — | US | claimed |
| US-20160333187-A1 | SYSTEMS AND METHODS FOR CONTROLLING THE DEGRADATION OF DEGRADABLE MATERIALS | DropWise Technologies Corp. | 2016-11-17 | — | — | US | claimed |
| US-20160296985-A1 | ARTICLES FOR MANIPULATING IMPINGING LIQUIDS AND ASSOCIATED METHODS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 2016-10-13 | — | — | US | claimed |
| WO-2016118697-A9 | METHODS, COMPOSITIONS, AND SYSTEMS FOR DELIVERING THERAPEUTIC AND DIAGNOSTIC AGENTS INTO CELLS | PHASERX, INC. (US) | 2016-09-29 | — | — | WO | claimed |
| WO-2016118697-A1 | METHODS, COMPOSITIONS, AND SYSTEMS FOR DELIVERING THERAPEUTIC AND DIAGNOSTIC AGENTS INTO CELLS | PHASERX, INC. (US) | 2016-07-28 | — | — | WO | claimed |
| US-20160159038-A1 | GRAFTED POLYMER SURFACES FOR DROPWISE CONDENSATION, AND ASSOCIATED METHODS OF USE AND MANUFACTURE | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 2016-06-09 | — | — | US | claimed |
| EP-2956248-A1 | GRAFTED POLYMER SURFACES FOR DROPWISE CONDENSATION, AND ASSOCIATED METHODS OF USE AND MANUFACTURE | Massachusetts Institute of Technology (US) | 2015-12-23 | — | — | EP | claimed |
| CN-105121036-A | Grafted polymer surfaces for dropwise condensation, and associated methods of use and manufacture | MASSACHUSETTS INST TECHNOLOGY | 2015-12-02 | — | — | CN | claimed |
| US-20140314982-A1 | GRAFTED POLYMER SURFACES FOR DROPWISE CONDENSATION, AND ASSOCIATED METHODS OF USE AND MANUFACTURE | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2014-10-23 | — | — | US | claimed |
| WO-2014127304-A1 | GRAFTED POLYMER SURFACES FOR DROPWISE CONDENSATION, AND ASSOCIATED METHODS OF USE AND MANUFACTURE | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2014-08-21 | — | — | WO | claimed |
| US-20100055463-A1 | HYDROPHOBIC CARBON BLACK INTERMEDIATE TRANSFER COMPONENTS | XEROX CORPORATION (US) | 2010-03-04 | — | — | US | claimed |
| US-7031589-B2 | Material for attenuating light signals with low reflectance in a fiber optic network | FURUKAWA ELECTRIC NORTH AMERICA (US) | 2006-04-18 | — | — | US | claimed |
| US-20040264908-A1 | Material for attenuating light signals with low reflectance in a fiber optic network | FURUKAWA ELECTRIC NORTH AMERICA, INC. | 2004-12-30 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230038687-A1 | METHODS, COMPOSITIONS, AND SYSTEMS FOR DELIVERING THERAPEUTIC AND DIAGNOSTIC AGENTS INTO CELLS | CD63, LIPA, NPC1L1 | THRB 4401/4885TSHR 3638/4885ALDH1A1 3899/4885 |
| US-20220031847-A1 | THERAPEUTIC METHODS | NUP205, HNRNPH3, FUS | THRB 3746/4885TSHR 1938/4885ALDH1A1 4243/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.